一个年轻的耐火性多发性骨髓瘤患者的透析独立性:一个病例报告
Ioannis Ntanasis-Stathopoulos1, Ilias Katsadouros1, Panagiotis Malandrakis1
1Plasma Cell Dyscrasias Unit, Department of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Oncology letters
|August 22, 2025
概括
在治疗复发性/ 耐药性多发性骨髓瘤方面,Teclistamab 显示出有效性,即使是在患有严重脏疾病的患者中也是如此. 这种双特异性抗体导致末期病患者的疾病缓解和功能改善.
科学领域:
- 癌症学
- 免疫疗法
- 肝脏病学
背景情况:
- 复发性/ 耐药性多发性骨髓瘤 (RRMM) 构成重大治疗挑战,特别是在功能障碍患者中.
- 现有疗法在患有严重功能障碍的患者中通常具有有限的疗效或禁用.
更多相关视频
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
